Faculty Opinions recommendation of Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis.

Author(s):  
Charles Pusey
2007 ◽  
Vol 5 (3) ◽  
pp. 25-34
Author(s):  
Maria V Sokolova ◽  
Eugene V Vasilyev ◽  
Andrey I Kozlov ◽  
Denis V Rebrikov ◽  
Svetlana S Senkeeva ◽  
...  

Genetically determined deficiency of the lactase enzyme in adults (primary hypolactasia) is a recessive trait. As shown earlier, in some European populations primary hypolactasia is determined by carrying the CC genotype at the single-nucleotide polymorphism (SNP) LCT*С/T-13910. In this work allele and genotype frequencies were estimated for the single-nucleotide polymorphism (SNP) LCT*C/ T-13910 in 7 samples (346 individuals in total), representing Eurasian populations (Saami, Mari, Russians from the Volga-Ural Area, Kazakhs, Uyghurs, Buriats, Arabs). For part of these groups and for some of the earlier studied groups the frequencies of the CC genotype are similar to the epidemiological-clinical data on hypolactasia frequency reported for respective or closely located populations (in Russians, Ukrainians, Byelorussians, Kola Saami, Mari, Komi-Permyaks, Udmurts, Pamir Mountain dwellers, and in Chukchi, Iranians and Arabs). For the Asian populations, the data are contradictory, and evaluation of genetic determination of hypolactasia in these populations requires further studies of larger samples. Considering association of primary hypolactasia with CC genotype in the Russian sample found by us earlier, the obtained results point that the CC genotype at SNP LCT*C/ T-13910 is the main genetic determinant of primary hypolactasia for populations of the European part of Russia.


PLoS ONE ◽  
2013 ◽  
Vol 8 (7) ◽  
pp. e69022 ◽  
Author(s):  
Sourabh Chand ◽  
Julia U. Holle ◽  
Marc Hilhorst ◽  
Matthew J. Simmonds ◽  
Stuart Smith ◽  
...  

2011 ◽  
Vol 10 (8) ◽  
pp. 1273-1279 ◽  
Author(s):  
Ai-ling ZHANG ◽  
Li ZHANG ◽  
Liang-zhi ZHANG ◽  
Xian-yong LAN ◽  
Cun-lei ZHANG ◽  
...  

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1312.2-1312
Author(s):  
V. Omelchenko ◽  
E. Letyagina ◽  
Y. Kurochkina ◽  
A. Akimova ◽  
A. Shevchenko ◽  
...  

Background:Rheumatoid arthritis (RA) is chronic progressive joint disease with erosions formation. Timely and effectiveness treatment is important due to quickly structural damage and progressive losing of active motion. Synthetic DMARDs didn’t have a sufficient effect. Using biological drugs seemed like a panacea, but according to investigations at least 30-40% RA-patients lost treatment efficiency. Biological drugs act through immune cascade, that’s why mutation in regulatory region of cytokine genes may partly determine treatment failure.Objectives:The objective of our study was to analyze the frequency ofIL1 T-31Csingle nucleotide polymorphism in patient with rheumatoid arthritis and its association with biological drugs prescribing.Methods:One hundred two Caucasian RA-patients (age – 56 yrs [45; 61]; DAS28 4.7 [3.8; 5.9]) were enrolled in our study. All of them had American College of Rheumatology (ACR)-defined RA (1987 classification criteria) and gave written inform consent. Single nucleotide polymorphismsIL1B T-31C(rs1143627),IL4 C-590T(rs2243250), IL10 C-592A (rs1800872),IL10 A-1082G(rs1800896) were determined by restriction fragment length polymorphism. Descriptive statistics, Chi-squared test were used for data analysis. Results are presented as median and 25th/75th percentiles (Me [25th percentile; 75th percentile]).Results:The most of SNPs analyzed had corresponded to the Hardy Weinberg equilibrium (HWE). The only exception was IL1B T-31C – the frequencies were differed statistically significant from HWE (p=0,03). Forty seven (46.1%) patients were treatment with biological drugs. Homozygotes IL1b -31CС were founded more frequently beside patients with biological treatment compare with other group (13 from 47 (27,7%) vs. 6 from 52 (11.5%), p=0,042). Other SNPs didn’t demonstrate any associations.Conclusion:Single nucleotide polymorphismIL1B T-31C(rs1143627) may be used for prognosis of basic anti-inflammatory therapy inefficiency and the needing for prescribing biological therapy.Disclosure of Interests:None declared


Sign in / Sign up

Export Citation Format

Share Document